BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 7690834)

  • 1. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.
    Matsumoto AK; Martin DR; Carter RH; Klickstein LB; Ahearn JM; Fearon DT
    J Exp Med; 1993 Oct; 178(4):1407-17. PubMed ID: 7690834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
    Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
    J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.
    Bradbury LE; Goldmacher VS; Tedder TF
    J Immunol; 1993 Sep; 151(6):2915-27. PubMed ID: 7690791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes.
    Fearon DT
    Curr Opin Immunol; 1993 Jun; 5(3):341-8. PubMed ID: 7688513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
    Fearon DT; Carter RH
    Annu Rev Immunol; 1995; 13():127-49. PubMed ID: 7542009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts.
    Cherukuri A; Shoham T; Sohn HW; Levy S; Brooks S; Carter R; Pierce SK
    J Immunol; 2004 Jan; 172(1):370-80. PubMed ID: 14688345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
    Sato S; Miller AS; Howard MC; Tedder TF
    J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
    J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
    Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
    J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.
    Matsumoto AK; Kopicky-Burd J; Carter RH; Tuveson DA; Tedder TF; Fearon DT
    J Exp Med; 1991 Jan; 173(1):55-64. PubMed ID: 1702139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
    Bouillie S; Barel M; Frade R
    J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
    Luxembourg AT; Cooper NR
    J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis.
    Maloney MD; Lingwood CA
    J Exp Med; 1994 Jul; 180(1):191-201. PubMed ID: 7516406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligation of membrane immunoglobulin leads to inactivation of the signal-transducing ability of membrane immunoglobulin, CD19, CD21, and B-cell gp95.
    Rijkers GT; Griffioen AW; Zegers BJ; Cambier JC
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8766-70. PubMed ID: 1701054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD72-mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3-kinase.
    Venkataraman C; Lu PJ; Buhl AM; Chen CS; Cambier JC; Bondada S
    Eur J Immunol; 1998 Oct; 28(10):3003-16. PubMed ID: 9808169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engaging CD19 or target of an antiproliferative antibody 1 on human B lymphocytes induces binding of B cells to the interfollicular stroma of human tonsils via integrin alpha 4/beta 1 and fibronectin.
    Behr S; Schriever F
    J Exp Med; 1995 Nov; 182(5):1191-9. PubMed ID: 7595190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD19/CD21 signal transduction complex of B lymphocytes.
    Tedder TF; Zhou LJ; Engel P
    Immunol Today; 1994 Sep; 15(9):437-42. PubMed ID: 7524521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the immune response by a soluble complement receptor of B lymphocytes.
    Hebell T; Ahearn JM; Fearon DT
    Science; 1991 Oct; 254(5028):102-5. PubMed ID: 1718035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens.
    Cherukuri A; Cheng PC; Pierce SK
    J Immunol; 2001 Jul; 167(1):163-72. PubMed ID: 11418645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.